• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗多发性硬化症发病率的急剧上升趋势是真实的吗?

Is the sharp increasing trend of multiple sclerosis incidence real in Iran?

作者信息

Hosseinzadeh Ali, Sedighi Behnaz, Kermanchi Jamshid, Heidari Mohammad, Haghdoost Ali Akbar

机构信息

Department of Epidemiology, School of Public Health, Shahroud University of Medical Sciences, Shahroud, Iran.

Neurology Research Center, Kerman University of Medical Science, Kerman, Iran.

出版信息

BMC Neurol. 2021 Jan 7;21(1):7. doi: 10.1186/s12883-020-02031-5.

DOI:10.1186/s12883-020-02031-5
PMID:33407243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7789321/
Abstract

BACKGROUND

Some epidemiologic studies have reported a sharp increase in multiple sclerosis (MS) incidence in different provinces in Iran. This report aimed to investigate more closely the increasing trend of MS incidence in the past 10 years in Iran.

METHODS

In this longitudinal study, the data for all MS patients meeting the McDonald criteria were obtained from a national registry, coordinated by the Ministry of Health (MOH). Joinpoint (JP) regression was used for time trend analysis of MS incidence and determine the optimal number of significant joinpoints. Finally, an annual percentage change (APC) in MS incidence for each segment of the trend line was estimated with 95% confidence interval.

RESULTS

The mean age of the patients and the mean annual incidence rate of MS were 30.9 ± 1.1 and 5.3 ± 1.9 per 100,000 population, respectively. The overall incidence rate of MS had increased significantly from 2.14 in 2006 to its peak (7.5) in 2014, per 100,000 population (APC = 12%, P < 0.001). The first JP was observed in 2011 in both male and female groups. The overall APC in the first segment was 22.6% (17.2-28.2%, p < 0.01). Besides, the corresponding APC values for males and females were 22.1% (14.7-30%, p < 0.01) and 22.5% (17.5-27.8%, p < 0.01), respectively. After 2011, the MS incidence underwent a more or less decreasing trend in both genders.

CONCLUSION

Contrary to previous studies, the MS incidence trend in Iran was rising just before 2011, and in the recent decade, Iran has a stable rate of MS cases.

摘要

背景

一些流行病学研究报告称,伊朗不同省份的多发性硬化症(MS)发病率急剧上升。本报告旨在更密切地调查伊朗过去10年MS发病率的上升趋势。

方法

在这项纵向研究中,所有符合麦克唐纳标准的MS患者的数据均来自由卫生部(MOH)协调的国家登记处。采用Joinpoint(JP)回归对MS发病率进行时间趋势分析,并确定显著连接点的最佳数量。最后,估计趋势线各段MS发病率的年度百分比变化(APC)及其95%置信区间。

结果

患者的平均年龄和MS的平均年发病率分别为30.9±1.1岁和每10万人中5.3±1.9例。MS的总体发病率已从2006年的每10万人中2.14例显著增加到2014年的峰值(7.5例)(APC=12%,P<0.001)。在男性和女性组中,第一个连接点均出现在2011年。第一段的总体APC为22.6%(17.2-28.2%,p<0.01)。此外,男性和女性的相应APC值分别为22.1%(14.7-30%,p<0.01)和22.5%(17.5-27.8%,p<0.01)。2011年后,男女MS发病率均呈或多或少的下降趋势。

结论

与先前的研究相反,伊朗的MS发病率在2011年前呈上升趋势,且在最近十年中,伊朗的MS病例数保持稳定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1d4/7789321/1de4b8be70ac/12883_2020_2031_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1d4/7789321/1de4b8be70ac/12883_2020_2031_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1d4/7789321/1de4b8be70ac/12883_2020_2031_Fig1_HTML.jpg

相似文献

1
Is the sharp increasing trend of multiple sclerosis incidence real in Iran?伊朗多发性硬化症发病率的急剧上升趋势是真实的吗?
BMC Neurol. 2021 Jan 7;21(1):7. doi: 10.1186/s12883-020-02031-5.
2
Incidence of multiple sclerosis in Iran: a nationwide, population-based study.伊朗多发性硬化症的发病率:一项全国范围内的基于人群的研究。
Public Health. 2019 Oct;175:138-144. doi: 10.1016/j.puhe.2019.07.013. Epub 2019 Aug 30.
3
Multiple sclerosis incidence temporal trend in the Northeast of Iran: Using the Empirical Bayesian method.伊朗东北部多发性硬化症发病率的时间趋势:采用经验贝叶斯方法
Mult Scler Relat Disord. 2023 Feb;70:104469. doi: 10.1016/j.msard.2022.104469. Epub 2022 Dec 15.
4
Multiple Sclerosis in Tehran: Rising Prevalence alongside Stabilizing Incidence - True Increase or Enhanced Diagnosis?德黑兰的多发性硬化症:发病率稳定的同时患病率上升——是真实增长还是诊断水平提高?
Arch Iran Med. 2019 Aug 1;22(8):429-434.
5
Geographic variations of multiple sclerosis in Iran: A population based study.伊朗多发性硬化症的地域差异:一项基于人群的研究。
Mult Scler Relat Disord. 2019 Feb;28:244-249. doi: 10.1016/j.msard.2019.01.001. Epub 2019 Jan 3.
6
Do socioeconomic factors affect the prevalence of multiple sclerosis in Iran?社会经济因素是否会影响伊朗多发性硬化症的患病率?
Acta Neurol Scand. 2019 Nov;140(5):328-335. doi: 10.1111/ane.13148. Epub 2019 Jul 31.
7
Joinpoint Regression Analysis of Trends in Multiple Sclerosis Incidence in Kuwait: 1980-2019.科威特多发性硬化症发病率趋势的 Joinpoint 回归分析:1980-2019 年。
Neuroepidemiology. 2020;54(6):472-481. doi: 10.1159/000511205. Epub 2020 Nov 11.
8
Estimated prevalence and incidence of multiple sclerosis in Iran.伊朗多发性硬化症的估计患病率和发病率。
Eur Neurol. 2014;72(5-6):370-4. doi: 10.1159/000365846. Epub 2014 Oct 18.
9
Temporal Incidence and Prevalence Trends of Multiple Sclerosis in Markazi Province, Iran.伊朗马尔卡齐省多发性硬化症的时间发病率和患病率趋势
Mult Scler Relat Disord. 2022 Apr;60:103691. doi: 10.1016/j.msard.2022.103691. Epub 2022 Feb 22.
10
Increasing prevalence of familial recurrence of multiple sclerosis in Iran: a population based study of Tehran registry 1999-2015.伊朗多发性硬化症家族复发患病率上升:基于德黑兰1999 - 2015年登记处的一项人群研究。
BMC Neurol. 2018 Feb 7;18(1):15. doi: 10.1186/s12883-018-1019-2.

引用本文的文献

1
Emerging epidemiological trends of multiple sclerosis among adults aged 20-54 years, 1990-2021, with projections to 2035: a systematic analysis for the global burden of disease study 2021.1990年至2021年20至54岁成年人中多发性硬化症的新出现的流行趋势及到2035年的预测:2021年全球疾病负担研究的系统分析
Front Neurol. 2025 Jul 10;16:1616245. doi: 10.3389/fneur.2025.1616245. eCollection 2025.
2
Age and sex as key determinants of multiple sclerosis incidence in Spain: a comprehensive analysis using the global burden of disease database (1990-2019).年龄和性别作为西班牙多发性硬化症发病率的关键决定因素:使用全球疾病负担数据库(1990 - 2019年)的综合分析
Neurol Sci. 2025 Mar;46(3):1277-1284. doi: 10.1007/s10072-024-07899-6. Epub 2024 Nov 30.
3

本文引用的文献

1
Mortality trend for multiple sclerosis in Italy during the period 1980-2015.1980 - 2015年期间意大利多发性硬化症的死亡率趋势。
Mult Scler Relat Disord. 2020 Sep;44:102240. doi: 10.1016/j.msard.2020.102240. Epub 2020 May 30.
2
Evidence of an increased prevalence of multiple sclerosis: a population-based study of Tehran registry during 1999-2018.多发性硬化症患病率增加的证据:1999-2018 年德黑兰注册中心的一项基于人群的研究。
BMC Neurol. 2020 May 2;20(1):169. doi: 10.1186/s12883-020-01747-8.
3
Multiple Sclerosis in Tehran: Rising Prevalence alongside Stabilizing Incidence - True Increase or Enhanced Diagnosis?
Pulp Sensitivity Testing in Multiple Sclerosis: Disease Duration and Sensory/Motor Associations-A Cross-Sectional Study.多发性硬化症中的牙髓敏感性测试:疾病持续时间与感觉/运动关联——一项横断面研究
Mult Scler Int. 2024 Sep 11;2024:6662518. doi: 10.1155/2024/6662518. eCollection 2024.
4
Prevalence of Multiple Sclerosis in Vitiligo Patients and Their First-Degree Relatives: Two Diseases with Similarities in Pathogenesis and Treatment.白癜风患者及其一级亲属中多发性硬化症的患病率:两种在发病机制和治疗方面具有相似性的疾病。
Dermatol Pract Concept. 2024 Jul 1;14(3):e2024103. doi: 10.5826/dpc.1403a103.
德黑兰的多发性硬化症:发病率稳定的同时患病率上升——是真实增长还是诊断水平提高?
Arch Iran Med. 2019 Aug 1;22(8):429-434.
4
Incidence of multiple sclerosis in Iran: a nationwide, population-based study.伊朗多发性硬化症的发病率:一项全国范围内的基于人群的研究。
Public Health. 2019 Oct;175:138-144. doi: 10.1016/j.puhe.2019.07.013. Epub 2019 Aug 30.
5
Geographic variations of multiple sclerosis in Iran: A population based study.伊朗多发性硬化症的地域差异:一项基于人群的研究。
Mult Scler Relat Disord. 2019 Feb;28:244-249. doi: 10.1016/j.msard.2019.01.001. Epub 2019 Jan 3.
6
Time-trend analysis and developing a forecasting model for the prevalence of multiple sclerosis in Kohgiluyeh and Boyer-Ahmad Province, southwest of Iran.伊朗西南部科吉卢耶-博耶艾哈迈德省多发性硬化症患病率的时间趋势分析及预测模型构建
Public Health. 2018 Jan;154:14-23. doi: 10.1016/j.puhe.2017.10.003. Epub 2017 Nov 10.
7
Multiple sclerosis-A disease on a dramatically rising trend in Iran: Review of possible reasons.多发性硬化症——一种在伊朗呈显著上升趋势的疾病:对可能原因的综述
Iran J Neurol. 2017 Jan 5;16(1):34-40.
8
Multiple Sclerosis Associated Risk Factors: A Case-Control Study.多发性硬化症相关危险因素:一项病例对照研究。
Iran J Public Health. 2015 Nov;44(11):1498-505.
9
Prevalence and Incidence of Multiple Sclerosis in Fars Province, Southern Iran.伊朗南部法尔斯省多发性硬化症的患病率和发病率
Iran J Med Sci. 2015 Sep;40(5):390-5.
10
Increased prevalence, incidence, and female predominance of multiple sclerosis in northern Japan.日本北部多发性硬化症的患病率、发病率和女性优势均增加。
J Neurol Sci. 2012 Dec 15;323(1-2):117-22. doi: 10.1016/j.jns.2012.08.032. Epub 2012 Sep 17.